Global Bioenergies SA

ENXTPA:ALGBE Stock Report

Market Cap: €14.8m

Global Bioenergies Future Growth

Future criteria checks 2/6

Global Bioenergies's earnings are forecast to decline at 4% per annum while its annual revenue is expected to grow at 27.6% per year. EPS is expected to grow by 15.1% per annum.

Key information

-4.0%

Earnings growth rate

15.1%

EPS growth rate

Chemicals earnings growth11.8%
Revenue growth rate27.6%
Future return on equityn/a
Analyst coverage

Low

Last updated17 Oct 2024

Recent future growth updates

Recent updates

Global Bioenergies SA's (EPA:ALGBE) Intrinsic Value Is Potentially 60% Above Its Share Price

Sep 18
Global Bioenergies SA's (EPA:ALGBE) Intrinsic Value Is Potentially 60% Above Its Share Price

Does Global Bioenergies (EPA:ALGBE) Have A Healthy Balance Sheet?

Jun 21
Does Global Bioenergies (EPA:ALGBE) Have A Healthy Balance Sheet?

Is Global Bioenergies (EPA:ALGBE) Using Debt Sensibly?

Jun 28
Is Global Bioenergies (EPA:ALGBE) Using Debt Sensibly?

Global Bioenergies (EPA:ALGBE) Has Debt But No Earnings; Should You Worry?

Oct 11
Global Bioenergies (EPA:ALGBE) Has Debt But No Earnings; Should You Worry?

Does Global Bioenergies (EPA:ALGBE) Have A Healthy Balance Sheet?

Oct 25
Does Global Bioenergies (EPA:ALGBE) Have A Healthy Balance Sheet?

Global Bioenergies (EPA:ALGBE) Shareholders Have Enjoyed An Impressive 187% Share Price Gain

Mar 20
Global Bioenergies (EPA:ALGBE) Shareholders Have Enjoyed An Impressive 187% Share Price Gain

Earnings and Revenue Growth Forecasts

ENXTPA:ALGBE - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20251-9-15-71
12/31/20240-9-12-61
6/30/20240-7-5-4N/A
3/31/20242-8-6-6N/A
12/31/20233-9-8-8N/A
9/30/20234-9N/AN/AN/A
6/30/20234-10-9-8N/A
3/31/20232-11-11-9N/A
12/31/20221-12-12-10N/A
9/30/20221-11N/AN/AN/A
6/30/20221-10-14-11N/A
3/31/20221-11-14-12N/A
12/31/20211-12-15-12N/A
9/30/20210-12N/AN/AN/A
6/30/20210-12-30-28N/A
3/31/20210-11-21-19N/A
12/31/20200-11-11-11N/A
9/30/20200-13-4-3N/A
6/30/20200-1245N/A
3/31/20200-12-3-3N/A
12/31/20190-14-11-10N/A
9/30/20191-13N/AN/AN/A
6/30/20191-12-16-16N/A
3/31/20191-13-12-12N/A
12/31/20181-14-8-7N/A
9/30/20181-16N/AN/AN/A
6/30/20180-17-5-5N/A
3/31/20180-16N/A-7N/A
12/31/20170-14N/A-9N/A
9/30/20170-11N/AN/AN/A
6/30/20171-10N/A-6N/A
3/31/20171-10N/A-8N/A
12/31/20161-11N/A-9N/A
9/30/20160-11N/AN/AN/A
6/30/20161-11N/A-9N/A
3/31/20161-11N/A-10N/A
12/31/20151-10N/A-9N/A
9/30/20151-9N/AN/AN/A
6/30/20151-8N/A-8N/A
3/31/20152-7N/A-8N/A
12/31/20142-6N/A-7N/A
9/30/20142-6N/AN/AN/A
6/30/20142-6N/A-7N/A
3/31/20141-6N/A-6N/A
12/31/20131-5N/A-5N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ALGBE is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: ALGBE is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: ALGBE is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: ALGBE's revenue (27.6% per year) is forecast to grow faster than the French market (5.6% per year).

High Growth Revenue: ALGBE's revenue (27.6% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if ALGBE's Return on Equity is forecast to be high in 3 years time


Discover growth companies